H型高血压患者的尿白蛋白肌酐比值变化及其临床意义
Changes of Urinary Albumin-Creatinine Ratio in Patients with H-Type Hypertension and Their Clinical Significance
摘要: 目的:探讨H型高血压患者的尿白蛋白肌酐比值改变及其临床意义。方法:104例原发性高血压患者根据血清中同型半胱氨酸是否小于10 μmol/L分为H型高血压组和单纯高血压组,48例健康成人作为健康对照组。检测三组尿白蛋白、尿肌酐、血尿素氮、血肌酐和血胱抑素C水平,分析上述指标的差异。结果:1) 三组的血尿素氮、血肌酐和血胱抑素C水平有显著差异(p < 0.05),但三组血尿素氮、血肌酐和血胱抑素C超过参考区间的比例虽有差异,但差异无统计学意义(p > 0.05);2) 三组间的尿白蛋白、尿肌酐和尿白蛋白肌酐比值有显著差异,差异有统计学意义(p < 0.05);3) H型高血压患者Hcy水平与尿白蛋白肌酐比值呈现明显正相关(r = 0.713, p = 0.010)。结论:尿白蛋白肌酐比值可用于明确H型高血压患者的早期肾损伤。
Abstract: Objective: To investigate the changes of urine albumin-creatinine ratio in patients with H-type hypertension and its clinical significance. Methods: 104 patients with essential hypertension were divided into H-type hypertension group and simple hypertension group according to whether their serum homocysteine was less than 10 μmol/L, and 48 healthy adults served as the healthy control group. The three groups of urine albumin, urine creatinine, blood urea nitrogen, blood creatinine and blood cystatin C levels were detected, and the differences in the above indicators were analyzed. Results: 1) The levels of blood urea nitrogen, blood creatinine and blood cystatin C in the three groups were significantly different (p <0.05), but the proportions of blood urea nitrogen, blood creatinine and blood cystatin C exceeding the reference interval among the three groups were different, the difference was not statistically significant (p > 0.05); 2) The ratios of urine albumin, urine creatinine and urine albumin creatinine among the three groups are significantly different, and the difference is statistically significant (p < 0.05); 3) The Hcy level of patients with H-type hypertension was significantly positively correlated with the ratio of urinary albumin and creatinine (r = 0.713, p = 0.010). Conclusion: The ratio of urine albumin to creatinine can be used to identify early renal injury in patients with H-type hypertension.
文章引用:毛辉, 欧志强, 黄洁群, 宁亮忠. H型高血压患者的尿白蛋白肌酐比值变化及其临床意义[J]. 临床医学进展, 2021, 11(10): 4566-4571. https://doi.org/10.12677/ACM.2021.1110671

参考文献

[1] Wang, Y., Zhang, J., Qian, Y., et al. (2018) Association of Homocysteine with Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients. Scientific Reports, 8, 595. [Google Scholar] [CrossRef] [PubMed]
[2] 文宇, 吴屹. 原发性高血压患者肾功能损害与肥胖的关系[J]. 中华老年心脑血管病杂志, 2017, 19(5): 472-474.
[3] 朱玲, 吴琳娜, 曾忠仪, 等. 早期肾损伤标志物在老年高血压肾损害检验中的应用[J]. 标记免疫分析与临床, 2018, 25(4): 524-528.
[4] Rodriguez-Iturbe, B., Pons, H. and Johnson, R.J. (2017) Role of the Immune System in Hypertension. Physiological Reviews, 97, 1127-1164. [Google Scholar] [CrossRef] [PubMed]
[5] 中国高血压防治指南修订委员会. 中国高血压防治指南(2010年修订版) [J]. 中国实用乡村医生杂志, 2012, 19(12): 1-15.
[6] Weber, G.J., Pushpakumar, S.B., Tyagi, S.C. and Sen, U. (2016) Homocysteine and Hydrogen Sulfide in Epigenetic, Metabolic and Microbiota Related Renovascular Hypertension. Pharmacological Research, 113, 300-312. [Google Scholar] [CrossRef] [PubMed]
[7] Weissgerber, T.L., Turner, S.T., Thomas, H., et al. (2016) Hypertension in Pregnancy and Future Cardiovascular Event Risk in Siblings. Journal of the American Society of Nephrology, 27, 894-902. [Google Scholar] [CrossRef
[8] Veeranki, S., Gandhapudi, S.K. and Tyagi, S.C. (2017) Interactions of Hyperhomocysteinemia and T Cell Immunity in Causation of Hypertension. Canadian Journal of Physiology and Pharmacology, 95, 239-246. [Google Scholar] [CrossRef] [PubMed]
[9] Rodríguez-Iturbe, B., Pons, H., Quiroz, Y., et al. (2014) The Immunological Basis of Hypertension. American Journal of Hypertension, 27, 1327-1337. [Google Scholar] [CrossRef] [PubMed]
[10] Griffin, K.A. (2017) Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease. Hypertension, 70, 687-694. [Google Scholar] [CrossRef
[11] 魏天祥, 崔世红, 陈娟, 等. 血清胱抑素C、尿β2-微球蛋白及随机尿微量白蛋白与肌酐比在妊娠期高血压疾病早期肾损伤中的临床应用[J]. 现代妇产科, 2018, 27(10): 766-768.
[12] 莫新玲, 杨锡恒, 谢婷, 等. H型高血压患者Hcy、Cyst-C、UACR与早期肾损害的关系[J]. 广东医学, 2015, 36(23): 3623-3626.
[13] 周茂松, 褚俊. 老年杓型高血压晨峰早期肾损害及Hcy、hs-CRP的检测价值[J]. 安徽医科大学学报, 2015(1): 94-97.